; (C) private corporations; and (D) nonprofit organizations. (4) Authorization of appropriations There is authorized to be appropriated to the Director to carry out this subsection up to $5,000,000 for each of the 3 fiscal years beginning with the first full fiscal year following the date of enactment of this Act. (c) Authority for Director of the National Institute of Standards and Technology to consult with experts on matters relating to per- and polyfluoroalkyl substances In carrying out this section, the Director of the National Institute of Standards and Technology may consult with Federal agencies, nongovernmental organizations, State and local governments, and science and research institutions determined by the Director to have scientific or material interest in reducing unnecessary occupational exposure to per- and polyfluoroalkyl substances by firefighters. 4. Hospital care and medical services for veterans and dependents exposed to per­fluo­ro­oc­ta­no­ic acid and other per- and polyfluoroalkyl substances (a) Hospital care and medical services for veterans (1) In general Paragraph (1) of section 1710(e) of title 38, United States Code, is amended by adding at the end the following new subparagraph: (G) (i) Beginning on the date that is 90 days after the date of the enactment of this subparagraph, subject to paragraph (2), a veteran who served on active duty in the Armed Forces at a covered military installation at which individuals were exposed to substances specified in clause (ii) is eligible for hospital care and medical services under subsection (a)(2)(F) for the diseases, illnesses, or conditions as specified in such clause, notwithstanding that there is insufficient medical evidence to conclude that such illness or condition is attributable to such service. (ii) The substances and diseases, illnesses, or conditions specified in this clause are the following: (I) With respect to exposure to per­fluo­ro­oc­ta­no­ic acid— (aa) diagnosed high cholesterol; (bb) ulcerative colitis; (cc) thyroid disease